Corrigendum to “Halofuginone enhances the anti-tumor effect of ALA-PDT by suppressing NRF2 signaling in cSCC” [Photodiagnosis and Photodynamic Therapy. 37 (2022) 102572]
Year: 2025
Type: erratum
Language: English
Subfield: Cancer Research
Domain: Life Sciences
Open Access status: gold
Estimated APC paid: $2,610
OpenAlex ID: W4411407015
